A detailed history of Allen Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Allen Wealth Management, LLC holds 2,790 shares of NVO stock, worth $291,722. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,790
Previous 3,090 9.71%
Holding current value
$291,722
Previous $441 Million 24.68%
% of portfolio
0.23%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$119.07 - $145.42 $35,721 - $43,625
-300 Reduced 9.71%
2,790 $332 Million
Q2 2024

Jul 19, 2024

SELL
$122.71 - $146.91 $79,761 - $95,491
-650 Reduced 17.38%
3,090 $441 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $21,443 - $28,543
210 Added 5.95%
3,740 $480 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $309,863 - $372,238
3,530 New
3,530 $365 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Allen Wealth Management, LLC Portfolio

Follow Allen Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Wealth Management, LLC with notifications on news.